Terumo Corporation ( TRUMY) - Stock Earnings
TRUMY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
TRUMY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 212.2 million USD | 1.9 billion USD |
| 2026Q1 | 168.1 million USD | 1.9 billion USD |
| 2026Q2 | 433.0 million USD | 1.9 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TRUMY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 702.6 million USD | 6.1 billion USD |
| 2025 | 783.2 million USD | 6.9 billion USD |
| 2026 | 902.2 million USD | 7.5 billion USD |
| 2026 Est. | — | — |
TRUMY
Price: $14.59
52 week price:
Dividend Yield: 1.26%
Payout Ratio Range:
Earnings Per Share: 0.58 USD
P/E Ratio: 28.16
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 21.0 billion